Clinical and laboratory observationsUrinary β2-microglobulin in premature infants with chorioamnionitis and chronic lung disease
Section snippets
Patients
Infants admitted to the Yokohama City University Hospital neonatal intensive care unit between March 2000 and February 2002 were eligible for study entry if they met the following criteria: (1) gestational age at birth ≤32 weeks, (2) spontaneously voided urine samples obtained using urine bags before 48 hours of age, (3) diagnosis of CLD after 28 days of survival, and (4) absence of major intraventricular hemorrhage (grades III and IV), congenital anomalies, and early-onset sepsis on admission.
Patients
There were no significant differences in birth weight and gestational age between the non-CAM and CAM group (1226 vs 1060 g, P = .8654 and 28.0 vs 28.0 weeks, P = .5251); however, the infants with CLD were smaller (892 vs 1234 g, P<.0001) and less mature (26.0 vs 29.0 weeks, P<.0001) than those without CLD. CLD developed in 14 infants (36.8%) in the CAM group and 4 (12.9%) in the non-CAM group, whereas CAM was diagnosed in 14 (77.8%) in the CLD group and 24 (47.1%) in the non-CLD group. Maternal
Discussion
We found several meaningful relationships between the neonatal urinary β2-MG levels measured on day 0 to 2 and the maternal CAM or neonatal CLD development. The urinary β2-MG levels were significantly higher in premature infants born to mothers with CAM than in infants without CAM. However, urinary β2-MG values were not elevated in approximately one third of the infants in the CAM group. One explanation would be that urinary β2-MG values rise if there is an accompanying fetal inflammatory
References (18)
- et al.
Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis
Am J Obstet Gynecol
(1994) - et al.
Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors
Br J Obstet Gynecol
(2002) - et al.
The fetal inflammatory response syndrome
Am J Obstet Gynecol
(1998) - et al.
Amniotic fluid cytokines (interleukin-6, tumor the risk for the development of bronchopulmonary dysplasia
Am J Obstet Gynecol
(1997) - et al.
Elevated interleukin-8 concentrations in amniotic fluid of mother whose neonates subsequently develop bronchopulmonary dysplasia
Eur J Obstet Gynecol Reprod Biol
(1998) - et al.
Chorioamnionitis and inflammation of the fetal lung
Am J Obstet Gynecol
(2001) - et al.
Isolation and properties of a molecular weight β2-microglobulin occurring in human biological fluids
J Biol Chem
(1968) - et al.
Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis
Pediatr Res
(1996) - et al.
Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis
J Matern Fetal Med
(1999)
Cited by (16)
Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants
2004, American Journal of Obstetrics and GynecologyThe association between βeta 2-microglobulin and bronchopulmonary dysplasia
2023, Turkish Journal of BiochemistryZinc supplementation in neonatal bronchopulmonary dysplasia: Is it beneficial?
2021, Current Pediatric ResearchHistological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and Meta-analysis
2021, Journal of Maternal-Fetal and Neonatal MedicineMelatonin supplementation as adjuvant therapy for the prevention of bronchopulmonary dysplasia in neonates
2020, Iranian Journal of Neonatology